| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/29/1997 | US5623782 Applying aryloxyphenoxyalkanecarboxylic acid herbicides in combination with sulfonylureas and imidazolinones |
| 04/28/1997 | CA2188900A1 Gene of the hop latent virus and methods for detecting the same |
| 04/28/1997 | CA2185407A1 Sustainable chick cell line infected with marek's disease virus |
| 04/28/1997 | CA2185406A1 Improvements in sustainable cell line for the production of marek's disease vaccines |
| 04/24/1997 | WO1997014966A1 Method of activating a novel ligand regulatory pathway |
| 04/24/1997 | WO1997014808A2 Herpesvirus vectors and their uses |
| 04/24/1997 | WO1997014799A1 Fibronectic binding protein b compounds |
| 04/24/1997 | WO1997014798A2 Polynucleotides and proteins coded thereby useful for controlling melolontha sp. cockchafers |
| 04/24/1997 | WO1997014796A1 Monoclonal antibody br110 and uses thereof |
| 04/24/1997 | WO1997014788A1 Method for inhibiting chymopapain and papain enzyme activity with zinc ions |
| 04/24/1997 | WO1997014785A2 Methods and compositions to improve germ cell and embryo survival and function |
| 04/24/1997 | WO1997014784A1 Method for inhibiting chymopapain and papain enzyme activity with polysaccharides of animal origin |
| 04/24/1997 | WO1997014783A1 Tissue-engineered bone repair using cultured periosteal cells |
| 04/24/1997 | WO1997014714A1 The aiolos gene |
| 04/24/1997 | WO1997014441A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | WO1997014435A1 FeLV THERAPEUTIC AGENT, METHOD OF ITS PREPARATION, AND METHOD OF TREATING FeLV INFECTION THEREWITH |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014295A1 Process for cloning paphiopedila |
| 04/24/1997 | WO1996034107A3 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/24/1997 | DE19642729A1 DNA encoding Bacillus popillae crystal protein |
| 04/24/1997 | DE19540487A1 Cell interaction system for induction of artificial 3-dimensional tissue |
| 04/24/1997 | CA2235075A1 Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles |
| 04/24/1997 | CA2234877A1 Herpesvirus vectors and their uses |
| 04/24/1997 | CA2234708A1 Animals with targeted gene deletion |
| 04/24/1997 | CA2233549A1 Method for restoring glucose responsiveness to insulin secretion |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769062A2 Novel internal ribosome entry site, vector containing same and therapeutical use thereof |
| 04/23/1997 | EP0769060A1 Fas associated proteins |
| 04/23/1997 | EP0769059A1 Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769052A2 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/23/1997 | EP0769048A1 Compartmentalized tissue culture flask |
| 04/23/1997 | EP0769025A1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 04/23/1997 | EP0769024A1 High-affinity melatonin receptors and uses thereof |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0769021A2 Transgenic fish in the treatment of diabetes |
| 04/23/1997 | EP0768894A1 Multi-stage cascade boosting vaccine |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768821A1 pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
| 04/23/1997 | EP0749472A4 Extracorporeal cell culture and transplantation kits |
| 04/23/1997 | EP0707599B1 Regulation of site-specific recombination by site-specific recombinase/nuclear receptor fusion proteins |
| 04/23/1997 | EP0400047B1 Modified hepatocytes and uses therefor |
| 04/23/1997 | EP0355117B2 Method for regulating plant growth |
| 04/23/1997 | CN1148408A Hematopoietic Protein and materials and method for making it |
| 04/23/1997 | CN1148342A Lymphoblastoid natural interferon alpha production |
| 04/22/1997 | US5623056 Immunomodulators |
| 04/22/1997 | US5623054 Crucifer AFT proteins and uses thereof |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622928 Glia activation factor and its production |
| 04/22/1997 | US5622856 High efficiency helper system for AAV vector production |
| 04/22/1997 | US5622855 Preserved, non-infectious control cells prepared by the modulation or modification of cultured cells |
| 04/22/1997 | US5622853 Specific antigens |
| 04/22/1997 | US5622852 Polynucleotide comprising sequence encoding mammalian bcl-xl/bcl-2 associated death promoter polypeptide |
| 04/22/1997 | US5622838 DNA preparation coding for ricin A and methods of using same |
| 04/22/1997 | US5622819 Centrifugal fermentation process |
| 04/22/1997 | US5622712 N-[ω, (ω-1)-dialkyloxy]- and N-[ω, (ω-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/22/1997 | CA2031265C Methods of detecting collagen degradation in vivo |
| 04/17/1997 | WO1997013865A1 Seed shattering |
| 04/17/1997 | WO1997013864A1 Juvenile hormone or one of its agonists as a chemical ligand to control gene expression in plants by receptor mediated transactivation |
| 04/17/1997 | WO1997013861A1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/17/1997 | WO1997013856A1 Improvements in or relating to protection against intracellular infection |
| 04/17/1997 | WO1997013852A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | WO1997013849A1 Apparatus and method for electrostatic endothelial cell seeding and dna transfection |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013840A1 Isolation and culture of porcine hepatocytes |
| 04/17/1997 | WO1997013787A1 Vegf-binding polypeptide |
| 04/17/1997 | WO1997013401A1 Method for the production of hybrid plants |
| 04/17/1997 | WO1997011156A3 Laser cell purification system |
| 04/17/1997 | WO1997002346A3 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2234604A1 Recombinant herpes virus vectors for expression in neuronal cells |
| 04/17/1997 | CA2232813A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 04/17/1997 | CA2232712A1 Juvenile hormone or one of its agonists as a chemical ligand to control gene expression in plants by receptor mediated transactivation |
| 04/17/1997 | CA2232155A1 Improvements in or relating to protection against intracellular infection |
| 04/16/1997 | EP0768379A1 Ubiquitous potassium-channel proteins and genes for the same |
| 04/16/1997 | EP0767911A1 Method for producing cytolytic t cells specific for a complex of peptide and mhc-molecule |
| 04/16/1997 | EP0767841A1 Taxane production in haploid-derived cell cultures |
| 04/16/1997 | EP0767840A2 Method for introducing foreign matter into higher eukaryotic cells |
| 04/16/1997 | EP0767838A1 Transgenic plants with an increased secondary substance content |
| 04/16/1997 | EP0767835A1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 04/16/1997 | EP0767833A1 Composition containing collagenase and chymopapain for isolating hepatocytes and pancreatic islet cells |
| 04/16/1997 | EP0767797A1 Plant peptide transport gene |
| 04/16/1997 | EP0767676A1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 04/16/1997 | EP0767605A1 Plant virus resistance gene and methods |
| 04/16/1997 | EP0632827B1 Method for producing high cell densities |
| 04/16/1997 | CN1147837A Recombinant adenoviral vector and methods of use |
| 04/16/1997 | CN1147833A Hepatitis A virus culture process |
| 04/15/1997 | US5621090 Nucleic acids encoding soluble human FLK-2 extracellular domain |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621079 Produced by culturing cell transformed by expression vector containing selected dna sequence |
| 04/15/1997 | US5620886 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/15/1997 | US5620855 Measuring uptake of compound into eucaryotic cell by contacting compound with cell that is transformed with a recombinant dna expression vector which encodes mammalian influx peptide transporter |
| 04/10/1997 | WO1997012989A1 Biologically-active polymers |
| 04/10/1997 | WO1997012985A2 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | WO1997012983A1 NOVEL POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE α- and β-SUBUNITS OF GLUTAMATE DEHYDROGENASES AND METHODS OF USE |
| 04/10/1997 | WO1997012982A1 DNA SEQUENCES CODING FOR A CINNAMOYL CoA REDUCTASE, AND APPLICATIONS THEREOF IN THE CONTROL OF LIGNIN CONTENTS IN PLANTS |
| 04/10/1997 | WO1997012979A1 Interleuken-3 (il-3) receptor agonists |